How should a medication be diluted in 5% dextrose (D5W) using sterile technique?

Medication Dilution in D5W: Evidence-Based Technique and Applications

When diluting medications in 5% dextrose (D5W), use sterile technique with single-dose vials when possible, cleanse multidose vial diaphragms with 70% alcohol before access, use sterile needles and syringes without reuse, and prepare dilutions in appropriate concentrations based on medication-specific requirements. 1

Sterile Technique Requirements

Core Principles for Parenteral Medication Preparation

• Never administer medication from a syringe to multiple patients, even if the needle is changed 1
• Use single-dose vials for parenteral medications whenever possible 1
• Do not combine leftover contents of single-use vials for later use 1

Multidose Vial Handling (When Single-Dose Not Available)

• Cleanse the access diaphragm with 70% alcohol before inserting any device into the vial 1
• Use a sterile device to access the vial and avoid touching the access diaphragm—both needle and syringe must be sterile 1
• Do not reuse a syringe even if the needle is changed 1
• Keep multidose vials away from the immediate patient treatment area to prevent contamination by spray or spatter 1
• Discard the multidose vial if sterility is compromised 1

Administration Set Management

• Use fluid infusion and administration sets (IV bags, tubing, and connections) for one patient only and dispose of appropriately 1
• Discard all syringes, containers, and multidose vials at end of case unless connected to patient 1

Medication-Specific D5W Dilution Protocols

High-Alert Medications

Epinephrine infusions: Dilute 1 mg in 250 mL D5W yielding 4 mcg/mL concentration, infuse at 1-4 mcg/min up to maximum 10 mcg/min for adults 2, 3

Dopamine for refractory hypotension: Administer at 2-20 mcg/kg/min in 500 mL D5W 2

Vasopressin: Dilute in either D5W or normal saline (25 U/250 mL) at 0.01-0.04 U/min 2

Sodium bicarbonate for tricyclic antidepressant toxicity: Prepare as 150 mEq NaHCO3 per liter of D5W 2

Chemotherapy Agents

Carboplatin desensitization: Reconstitute in D5W with side stream infusion at 10 mL/h, following 12-step protocol with concentrations ranging from 0.005332 mg/mL to 0.504846 mg/mL 1

Oxaliplatin: Reconstitute 120 mg/24 mL with 200 mL D5W for final concentration of 0.5385 mg/mL 1

Pediatric Medications

Prostaglandin E1: Infuse at 0.05-0.10 mcg/kg/min in D5W for ductal-dependent cardiac lesions 3

Morphine: Infuse at 0.15-0.25 mg/kg per dose over 10 minutes in D5W 3

Labeling and Verification Requirements

Mandatory Labeling Standards

• Every medication must be labeled with name, date, and concentration 1
• Use preprinted, color-coded labels per ISO standards when available 1
• Avoid abbreviations and trailing zeros 1
• Any unlabeled syringe must be immediately discarded 1

Verification Process

• Read and verify every vial, ampoule, and syringe label before administration 1
• Use barcode system with audible and visual cues when available 1
• Perform two-person check for high-risk medications and weight-based doses 1
• For single-person check, perform careful double verification 1

D5W-Specific Compatibility Considerations

Medication Stability in D5W

Amphotericin B: Stable at concentrations of 0.92-1.40 mg/mL when stored at 6°C and 25°C for up to 36 hours 4

Cyclosporine: Stable in D5W in glass containers or polyvinyl chloride minibags for 24 hours (use glass or within 6 hours in PVC due to plasticizer leaching) 5

Critical Incompatibility Warning

Monoclonal antibodies formulated at acidic pH (≤6.5) form insoluble aggregates when mixed with D5W and serum—this includes certain therapeutic mAbs that undergo isoelectric precipitation with serum proteins at the blood-IV interface 6

• mAbs formulated at neutral pH (7.2-7.5) or in buffers containing sodium chloride are compatible with D5W 6
• Always verify product-specific compatibility before dilution 6

Preparation Environment and Timing

Sterility Maintenance

• D5W does not support bacterial growth for 24 hours after spiking when standard sterile technique is used in perioperative environments 7
• Despite this finding, US Pharmacopeia Chapter <797> recommends administration begin no later than 1 hour after preparation of compounded sterile preparations 7

Pharmacy vs. Bedside Preparation

• Pharmacy should prepare all compounded and diluted drugs when possible 1
• Provider-prepared dilutions of high-risk medications require two-person check or careful double verification 1
• Prefilled syringes should be used whenever possible to minimize provider preparation 1

Monitoring Requirements When Using D5W

Blood Glucose Monitoring

• Monitor blood glucose levels when using D5W, especially in diabetic patients 2, 3
• For insulin infusions in D5W-containing fluids, check blood glucose every 1-2 hours 1, 3

Fluid Overload Surveillance

• Monitor for fluid overload in patients with cardiac or renal compromise regardless of diluent choice 2
• In cardiac or renal compromise, limit D5W rates to ≤100 mL/hour 3, 8

Common Pitfalls to Avoid

• Never reconstitute doses of 2 mg glucagon in manufacturer-supplied diluent—use sterile water instead to prevent nausea/vomiting from delayed gastric emptying 1
• Do not use D5W for volume resuscitation—only ~80-100 mL per liter expands plasma volume as most water shifts intracellularly after dextrose metabolism 8
• Avoid storing cyclosporine admixtures in PVC containers beyond 6 hours due to plasticizer leaching and drug loss to tubing (~10% loss through 70-inch PVC tubing) 5
• For methacholine challenge testing, prepare serial dilutions using sterile technique with specific doubling or quadrupling concentration schemes 1